tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market
MCRB
Seres Therapeutics
RESEARCH TOOLSreports
Want to see MCRB full AI Analyst Report?

Seres Therapeutics (MCRB) Income Statement

1,084 Followers

Seres Therapeutics Income Statement

Last quarter (Q1 2026), Seres Therapeutics's total revenue was $358.00K, an increase of Infinity% from the same quarter last year. In Q1, Seres Therapeutics's net income was $-19.91M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 789.00K$ 0.00$ 0.00$ 0.00$ 144.93M
Gross Profit
$ -3.34M$ -3.53M$ 0.00$ 0.00$ 144.93M
Operating Expenses
$ 90.63M$ 117.78M$ 195.10M$ 179.91M$ 209.42M
Depreciation and Amortization
$ 4.13M$ 5.47M$ 6.24M$ 6.63M$ 5.95M
EBITDA
$ -89.84M$ -120.30M$ -181.42M$ -170.93M$ -56.72M
Operating Income
$ -93.97M$ -121.31M$ -195.10M$ -179.91M$ -64.49M
Other Income/Expenses
$ 99.67M$ -4.46M$ 4.97M$ -3.67M$ -1.08M
Pretax Income
$ 5.70M$ -125.77M$ -190.13M$ -183.58M$ -65.58M
Net Income
$ 5.70M$ 136.00K$ -113.72M$ -250.16M$ -65.58M
Per Share Metrics
Basic EPS
$ 0.64$ -18.86$ -17.77$ -46.29$ -14.30
Diluted EPS
$ 0.64$ -18.86$ -17.77$ -46.29$ -14.30
Weighted Average Shares Outstanding
 8.86M 7.77M 6.40M 5.40M 4.59M
Weighted Average Shares Outstanding (Diluted)
 8.87M 7.77M 6.40M 5.40M 4.59M
Currency in USD

Seres Therapeutics Earnings and Revenue History